Celcuity is a publicly traded, clinical‑stage biotechnology company headquartered in Minneapolis that seeks to extend the lives of cancer patients by developing targeted therapies for multiple solid‑tumor indications. Its lead candidate, gedatolisib, is an intravenously administered, first‑in‑class PI3K/AKT/mTOR pathway inhibitor whose mechanism of action and pharmacokinetics differ markedly from existing PI3K or mTOR agents. Phase 3 programs focus on HR⁺/HER2⁻ advanced breast cancer in first‑ and second‑line settings, while a Phase 1b/2 study evaluates the drug in combination with darolutamide for metastatic castration‑resistant prostate cancer. Celcuity’s approach centers on a deeper understanding of the cellular drivers of tumor growth, positioning it as a distinctive player in the oncology drug‑development landscape.
Open Positions
Director, Medical Science Liaison, New England
3+ years of related pharmaceutical Medical Science Liaison experience, Breast Cancer experience, Knowledge of clinical research design and GCP in the oncology area
Director, Medical Science Liaison, North Central US
MD, PharmD, or PhD in Life Sciences, solid tumor oncology experience, 3+ years of related pharmaceutical Medical Science Liaison experience
Director, Medical Science Liaison, Carolinas
MD, PharmD, or PhD in Life Sciences, 3+ years of related pharmaceutical Medical Science Liaison experience, and experience in solid tumor oncology
Senior Medical Director, Clinical Development
MD with solid tumor clinical trials experience, 8-10 years' clinical development experience, and thorough knowledge of clinical trial design, methodology and statistical concepts
Associate Director, Field Operations
Bachelor's degree, 7+ years sales operations experience, significant experience partnering with a sales team, and knowledge of sales incentive compensation concepts, workforce sizing, territory alignment, and targeting